RACHESKY MARK H MD 4

What Happened

• Dr. Mark H. Rachesky, a director and disclosed 10% owner of Lionsgate Studios Corp. (LION), was granted 7,983 common shares on April 1, 2026. The grant is reported as an award/acquisition (code A) at $9.52 per share, with a total reported value of $75,998. This was a compensation grant (director fees), not an open-market purchase or sale.

Key Details

• Transaction date and price: April 1, 2026 — 7,983 shares at $9.52 each (total $75,998).
• Shares owned after transaction: Not specified in the provided filing details.
• Notable footnotes: F1 indicates these shares were granted as director fees. Other footnotes (F10–F14 and related notes) state that shares may be held for the accounts of various MHR-managed funds (e.g., MHR Institutional Partners III/IV) and that Institutional Advisors, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own those fund-held shares, though they disclaim ownership except for pecuniary interest.
• Filing timeliness: Not indicated in the information provided.

Context

• This was a compensation grant to a director (routine director fees) rather than a market buy or sale; such awards compensate service and do not by themselves signal a trading decision. Because Dr. Rachesky is reported as a 10% owner through various MHR-related funds, holdings may reflect institutional positions managed through affiliated entities rather than direct personal trading.